Literature DB >> 17660135

Colostomy for large bowel anomalies in children: a case controlled study.

S O Ekenze1, N E N Agugua-Obianyo, C C Amah.   

Abstract

BACKGROUND: In children, colostomy may be required as a crucial part of treatment of some congenital anomalies of the large bowel. The procedure is associated with significant complications. This study reviews the morbidity and mortality of colostomy formation and closure for large bowel anomalies over a 10-year period in southeast Nigeria.
METHODS: Evaluation of 182 colostomies and 146 colostomy closures performed in children at the University of Nigeria Teaching Hospital Enugu from January 1995 to December 2004.
RESULTS: Hirschsprung's disease (106) and anorectal malformation (76) were the large bowel anomalies requiring colostomy. Of these, 133 (73.1%) were boys, while 49 (26.9%) were girls and their age ranged from 3 days to 15 years (mean 2.8 years). For anorectal malformation, the mean age at colostomy formation was 15.5 days (range 3-75 days), while in Hirschsprung's disease the mean age was 4.6 years (range 8 days-15 years). Ninety-two children (50.5%) had defunctioning colostomy and 90 (49.5%) had loop colostomy, with 177 (97.3%) of these sited in the transverse colon, while the remaining 5 (2.7%) were sited in the sigmoid colon. There were 123 complications that developed in 79 (43.4%) children. Skin excoriation (40 cases) and prolapse (37 cases) were the commonest complications. Other complications included wound infection (20 cases), superficial wound dehiscence (9 cases), stoma stenosis (5 cases), stoma retraction (5 cases), stoma bleeding (3 cases) and 2 cases each of stoma necrosis and burst abdomen. The complications were not dependent on the primary indication but prolapse occurred more frequently in children with Hirschsprung's disease who had colostomy after 5 years of age (P<0.001). Loop colostomy had higher complication rate than defunctioning colostomy (P<0.001). Colostomy revision was required in 15 patients. Death directly related to colostomy formation occurred in 3 (1.6%) patients from severe infection. Complications following colostomy closure (20 cases) occurred in 17 children and include wound infection (11 cases), stitch granuloma (5 cases), and 2 cases each of small bowel obstruction and incisional hernia. These were not related to the duration of the colostomy.
CONCLUSIONS: A significant number of colostomies for large bowel anomalies are constructed late in our setting. This is largely due to delayed presentation in Hirschsprung's disease and may be associated with increased morbidity. Loop colostomy is associated with higher rate of complication and as much as possible should be performed less often.

Entities:  

Mesh:

Year:  2007        PMID: 17660135     DOI: 10.1016/j.ijsu.2007.01.008

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  5 in total

1.  Problems and outcome of Hirschsprung's disease presenting after 1 year of age in a developing country.

Authors:  S O Ekenze; C Ngaikedi; A A Obasi
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

2.  Ostomy complicatıons in patients with anorectal malformations.

Authors:  Billur Demirogullari; Yavuz Yilmaz; Gulsen Ekingen Yildiz; I O Ozen; Ramazan Karabulut; Zafer Turkyilmaz; Kaan Sonmez; A Can Basaklar; Nuri Kale
Journal:  Pediatr Surg Int       Date:  2011-10       Impact factor: 1.827

3.  A review of anaesthesia for emergency laparotomy in paediatric intestinal obstruction in Enugu, Nigeria.

Authors:  Ugochukwu Vincent Okafor; Jerome Azike
Journal:  Pan Afr Med J       Date:  2009-10-16

4.  Colostomy closure: how to avoid complications.

Authors:  Andrea Bischoff; Marc A Levitt; Taiwo A Lawal; Alberto Peña
Journal:  Pediatr Surg Int       Date:  2010-11       Impact factor: 1.827

Review 5.  Congenital anomalies in low- and middle-income countries: the unborn child of global surgery.

Authors:  Nicole A Sitkin; Doruk Ozgediz; Peter Donkor; Diana L Farmer
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.